PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Clinical trials for PSP - PROGRESSIVE SUPRANUCLEAR PALSY explained in plain language.
Never miss a new study
Get alerted when new PSP - PROGRESSIVE SUPRANUCLEAR PALSY trials appear
Sign up with your email to follow new studies for PSP - PROGRESSIVE SUPRANUCLEAR PALSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vaccine tame this rare brain disease?
Disease control Not yet recruitingThis study tests a vaccine called AADvac1 in 146 people with progressive supranuclear palsy (PSP), a rare brain disorder that affects movement and thinking. The vaccine aims to target a protein linked to the disease and slow its progression. Participants will receive injections o…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for PSP: experimental drug LM11A-31 enters key trial
Disease control Not yet recruitingThis Phase 2 trial tests whether the drug LM11A-31 can slow the progression of Progressive Supranuclear Palsy (PSP), a rare brain disorder that affects movement and balance. About 147 people with early-stage PSP will receive either the drug or a placebo twice daily for several mo…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC